Clinical Neuroscience Solutions, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Jacksonville FL United States (1996)

Organization Overview

First Clinical Trial
2010
NCT01246908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Clinical Neurosciences Solutions, Inc.

Active Ingredients

Drugs in Phase 2 Trials (6)

artefenomel (3 trials)

ctx-4430 (1 trial)

cx157 (1 trial)

dsm265 (2 trials)

mmv390048 (2 trials)

primaquine (1 trial)

Drugs in Phase 1 Trials (2)

piperaquinoline (1 trial)

(+)-sj000557733 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Treatment-Resistant (Phase 2)

Malaria (Phase 2)

Malaria, Falciparum (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial APIs: 8